메뉴 건너뛰기




Volumn 30, Issue 1, 2006, Pages 125-130

Deferiprone or deferoxamine vs. combination therapy in patients with β-thalassemia major: A case study in Taiwan

Author keywords

Thalassemia major; Combined therapy; Deferiprone (L1); Deferoxamine (DFO)

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFERIPRONE; DEFEROXAMINE;

EID: 33645062405     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260500455581     Document Type: Conference Paper
Times cited : (20)

References (11)
  • 1
    • 0031784438 scopus 로고    scopus 로고
    • Combined therapy with deferiprone and desferrioxamine
    • Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol 1998; 103(2):361-364.
    • (1998) Br J Haematol , vol.103 , Issue.2 , pp. 361-364
    • Wonke, B.1    Wright, C.2    Hoffbrand, A.V.3
  • 2
    • 0242584372 scopus 로고    scopus 로고
    • Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients
    • Mourad FH, Hoffbrand AV, Sheikh-Taha M, Koussa S, Khoriaty AI, Taher A. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol 2003; 121(1):187-189.
    • (2003) Br J Haematol , vol.121 , Issue.1 , pp. 187-189
    • Mourad, F.H.1    Hoffbrand, A.V.2    Sheikh-Taha, M.3    Koussa, S.4    Khoriaty, A.I.5    Taher, A.6
  • 4
    • 0042943205 scopus 로고    scopus 로고
    • Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
    • Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood 2003; 102(5):1583-1587.
    • (2003) Blood , vol.102 , Issue.5 , pp. 1583-1587
    • Cohen, A.R.1    Galanello, R.2    Piga, A.3    De Sanctis, V.4    Tricta, F.5
  • 6
    • 0034094839 scopus 로고    scopus 로고
    • Safety profile of the oral iron chelator deferiprone: A multicentre study
    • Cohen AR, Galanello R, Piga A, Dipalma A, Vullo C, Tricta F. Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol 2000; 108(2):305-312.
    • (2000) Br J Haematol , vol.108 , Issue.2 , pp. 305-312
    • Cohen, A.R.1    Galanello, R.2    Piga, A.3    Dipalma, A.4    Vullo, C.5    Tricta, F.6
  • 7
    • 0032887235 scopus 로고    scopus 로고
    • Deferiprone: A review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases
    • Barman Balfour JA, Foster RH. Deferiprone: a review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases. Drugs 1999; 58(3):553-578.
    • (1999) Drugs , vol.58 , Issue.3 , pp. 553-578
    • Barman Balfour, J.A.1    Foster, R.H.2
  • 8
    • 0037630378 scopus 로고    scopus 로고
    • Role of deferiprone in chelation therapy for transfusional iron overload
    • Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003; 102(1):17-24.
    • (2003) Blood , vol.102 , Issue.1 , pp. 17-24
    • Hoffbrand, A.V.1    Cohen, A.2    Hershko, C.3
  • 9
    • 0036721452 scopus 로고    scopus 로고
    • Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent β-thalassemia
    • Wanless IR, Sweeney G, Dhillon AP, Guido M, Piga A, Galanello R, Gamberini MR, Schwartz E, Cohen AR. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent β-thalassemia. Blood 2002; 100(5):1566-1569.
    • (2002) Blood , vol.100 , Issue.5 , pp. 1566-1569
    • Wanless, I.R.1    Sweeney, G.2    Dhillon, A.P.3    Guido, M.4    Piga, A.5    Galanello, R.6    Gamberini, M.R.7    Schwartz, E.8    Cohen, A.R.9
  • 10
    • 0033693878 scopus 로고    scopus 로고
    • Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)
    • Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Transfus Sci 2000; 23(3):211-223.
    • (2000) Transfus Sci , vol.23 , Issue.3 , pp. 211-223
    • Kontoghiorghes, G.J.1    Pattichi, K.2    Hadjigavriel, M.3    Kolnagou, A.4
  • 11
    • 3042777499 scopus 로고    scopus 로고
    • Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major
    • Wu KH, Chang JS, Tsai CH, Peng CT. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major. Ann Hematol 2004; 83(7):471-473.
    • (2004) Ann Hematol , vol.83 , Issue.7 , pp. 471-473
    • Wu, K.H.1    Chang, J.S.2    Tsai, C.H.3    Peng, C.T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.